Abstract
It has been known for more than 2000 years that several skin diseases improve upon exposure to the sun. However, it was not until the end of the 19th century before Niels R. Finsen started to use sunlight as well as electric light for the treatment of skin tuberculosis.1 He was awarded the Nobel Prize in 1903 “in recognition of his contribution to the treatment of diseases, especially lupus vulgaris, with concentrated light radiation, whereby he has opened a new avenue for medical science.” The carbon arc lamp initially used by Finsen was later shown to emit longwave ultraviolet radiation.1 Another device, still successfully used in some circumscribed itchy skin diseases, was constructed by Gustav Bucky in 1929. This device produced ionizing radiation employing ultrasoft X-rays (0.07-0.4 nm), which Bucky called “grenz rays” since he believed that the biological effects of these rays resemble those of X-rays in some ways and ultraviolet rays in other ways.2
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Møller KI, Kongshoj B, Philipsen PA, Thomsen VO, Wulf HC. How Finsen’s light cured lupus vulgaris. Photodermatol Photoimmunol Photomed. 2005;21(3):118-124.
Lindelöf B. Grenz ray therapy in dermatology. An experimental, clinical and epidemiological study. Acta Derm Venereol Suppl (Stockh). 1987;132:1-67.
McGregor JM. The history of human photobiology. In: ED Hawk JLM. Arnold eds. Photodermatology. Oxford University Press; 1999.
Ingram JT. The approach to psoriasis. Br Med J. 1953;2(4836):591-594.
Parrish JA, Fitzpatrick TB, Tanenbaum L, Pathak MA. Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light. N Engl J Med. 1974;291(23):1207-1211.
Rivard J, Lim HW. The use of 308-nm excimer laser for dermatoses: experience with 34 patients. J Drugs Dermatol. 2006;5(6):550-554.
Gilchrest BA, Soter NA, Stoff JS, Mihm MC Jr. The human sunburn reaction: histologic and biochemical studies. J Am Acad Dermatol. 1981;5(4):411-422.
Ruzicka T, Walter JF, Printz MP. Changes in arachidonic acid metabolism in UV-irradiated hairless mouse skin. J Invest Dermatol. 1983;81:300-303.
Black AK, Fincham N, Greaves MW, Hensby CN. Time course changes in levels of arachidonic acid and prostaglandins D2, E2, F2 alpha in human skin following UVB irradiation. Br J Clin Pharmacol. 1980;10:453-457.
Hawk JL, Black AK, Jaenicke KF, et al. Increased concentrations of arachidonic acid, prostaglandins E2, D2, and 6-oxo-F1α, and histamine in human skin following UVA irradiation. J Invest Dermatol. 1983;80:496-499.
Grandjean-Laquerriere A, Le Naour R, Gangloff SC, Guenounou M. Differential regulation of TNF-alpha, IL-6 and IL-10 in UVB-irradiated human keratinocytes via cyclic AMP/protein kinase A pathway. Cytokine. 2003;23(4-5):138-149.
Schwarz T. Mechanisms of UV-induced immunosuppression. Keio J Med. 2005;54(4):165-171.
Norris DA, Lyons MB, Middleton MH, Yohn JJ, Kashihara-Sawami M. Ultraviolet radiation can either suppress or induce expression of intercellular adhesion molecule 1 (ICAM-1) on the surface of cultured human keratinocytes. J Invest Dermatol. 1990;95(2):132-138.
Hruza LL, Pentland AP. Mechanisms of UV-induced inflammation. J Invest Dermatol. 1993;100(1):35S-41S.
Wallengren J, Ekman R, Möller H. Substance P and vasoactive intestinal peptide in bullous and inflammatory skin disease. Acta Derm Venereol (Stockh). 1986;66:23-28.
Gillardon F, Moll I, Michel S, Benrath J, Weihe E, Zimmermann M. Calcitonin gene-related peptide and nitric oxide are involved in ultraviolet radiation-induced immunosuppression. Eur J Pharmacol. 1995;293(4):395-400.
Legat FJ, Griesbacher T, Schicho R, et al. Repeated subinflammatory ultraviolet B irradiation increases substance P and calcitonin gene-related peptide content and augments mustard oil-induced neurogenic inflammation in the skin of rats. Neurosci Lett. 2002;329:309-313.
Scholzen TE, Brzoska T, Kalden DH, et al. Effect of ultraviolet light on the release of neuropeptides and neuroendocrine hormones in the skin: mediators of photodermatitis and cutaneous inflammation. J Investig Dermatol Symp Proc. 1999;4(1):55-60.
Wallengren J. Substance P antagonist inhibits immediate and delayed type cutaneous hypersensitivity reactions.Br J Dermatol. 1991;124(4):324-328.
Bondesson L, Nordlind K, Mutt V. Lidén S. Vasoactive intestinal polypeptide inhibits the established allergic contact dermatitis in humans. Ann N Y Acad Sci. 1996;805:702-707.
Wallengren J. Dual effects of CGRP-antagonist on allergic contact dermatitis in human skin. Contact Dermatitis. 2000;43(3):137-143.
Wallengren J. Neuroanatomy and neurophysiology of itch. Dermatol Ther. 2005;18(4):292-303.
Szepietowski JC, Morita A. Tsuji T. Ultraviolet B induces mast cell apoptosis: a hypothetical mechanism of ultraviolet B treatment for uraemic pruritus. Med Hypotheses. 2002;58(2):167-170.
Fjellner B, Hagermark O. Influence of ultraviolet light on itch and flare reactions in human skin induced by histamine and the histamine liberator compound 48/80. Acta Derm Venereol. 1982;62:137-140.
Wallengren J. Vasoactive peptides in the skin. J Investig Dermatol Symp Proc. 1997;2(1):49-55.
Wallengren J, Sundler F. Phototherapy induces loss of epidermal and dermal nerve fibers. Acta Derm Venereol (Stockh). 2004;84:111-115.
Kumakiri M, Hashimoto K, Willis I. Biological changes of human cutaneous nerves caused by ultraviolet irradiation: an ultrastructural study. Br J Dermatol. 1978;99(1):65-75.
Gilchrest BA, Rowe JW, Brown RS, Steinman TI, Arndt KA. Ultraviolet phototherapy of uremic pruritus. Long-term results and possible mechanism of action. Ann Intern Med. 1979;91(1):17-21.
Jekler J, Bergbrant IM, Faergemann J. Larkö O. The in vivo effect of UVB radiation on skin bacteria in patients with atopic dermatitis. Acta Derm Venereol. 1992;72(1):33-36.
Faergemann J, Larkö O. The effect of UV-light on human skin microorganisms. Acta Derm Venereol. 1987;67(1):69-72.
Samson Yashar S, Gielczyk R, Scherschun L, Lim HW. Narrow-band ultraviolet B treatment for vitiligo, pruritus, and inflammatory dermatoses. Photodermatol Photoimmunol Photomed. 2003;19(4):164-168.
Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol. 1980;92:44-47.
Jekler J, Larkö O. UVB phototherapy of atopic dermatitis. Br J Dermatol. 1988;119(6):697-705.
Jekler J, Larkö O. Combined UVA-UVB versus UVB phototherapy for atopic dermatitis: a paired-comparison study. J Am Acad Dermatol. 1990;22(1):49-53.
Jekler J, Larkö O. Phototherapy for atopic dermatitis with ultraviolet A (UVA), low-dose UVB and combined UVA and UVB: two paired-comparison studies. Photodermatol Photoimmunol Photomed. 1991;8(4):151-156.
Jekler J, Larkö O. UVA solarium versus UVB phototherapy of atopic dermatitis: a paired-comparison study. Br J Dermatol. 1991;125(6):569-572.
Hjerppe M, Hasan T, Saksala I, Reunala T. Narrow-band UVB treatment in atopic dermatitis. Acta Derm Venereol. 2001;81(6):439-440.
Der-Petrossian M, Seeber A, Hönigsmann H, Tanew A. Half-side comparison study on the efficacy of 8-methoxypsoralen bath-PUVA versus narrow-band ultraviolet B phototherapy in patients with severe chronic atopic dermatitis. Br J Dermatol. 2000;142(1):39-43.
Meduri NB, Vandergriff T, Rasmussen H, Jacobe H. Phototherapy in the management of atopic dermatitis: a systematic review. Photodermatol Photoimmunol Photomed. 2007;23(4):106-112.
von Kobyletzki G, Pieck C, Hoffmann K, Freitag M, Altmeyer P. Medium-dose UVA1 cold-light phototherapy in the treatment of severe atopic dermatitis. J Am Acad Dermatol. 1999;41(6):931-937.
Reynolds NJ, Franklin V, Gray JC, Diffey BL, Farr PM. Narrow-band ultraviolet B and broad-band ultraviolet A phototherapy in adult atopic eczema: a randomised controlled trial. Lancet. 2001;357(9273):2012-2016.
Legat FJ, Hofer A, Brabek E, Quehenberger F, Kerl H, Wolf P. Narrowband UV-B vs medium-dose UV-A1 phototherapy in chronic atopic dermatitis. Arch Dermatol. 2003;139(2):223-234.
Baltás E, Csoma Z, Bodai L, Ignácz F, Dobozy A, Kemény L. Treatment of atopic dermatitis with the xenon chloride excimer laser. J Eur Acad Dermatol Venereol. 2006;20(6):657-660.
Olafsson JH, Larkö O, Roupe G, Granerus G. Bengtsson U. Treatment of chronic urticaria with PUVA or UVA plus placebo: a double-blind study. Arch Dermatol Res. 1986;278(3):228-231.
Berroeta L, Clark C, Ibbotson SH, Ferguson J, Dawe RS. Narrow-band (TL-01) ultraviolet B phototherapy for chronic urticaria. Clin Exp Dermatol. 2004;29(1):97-98.
Hannuksela M, Kokkonen EL. Ultraviolet light therapy in chronic urticaria. Acta Derm Venereol. 1985;65(5):449-450.
Rombold S, Lobisch K, Katzer K, Grazziotin TC, Ring J, Eberlein B. Efficacy of UVA1 phototherapy in 230 patients with various skin diseases. Photodermatol Photoimmunol Photomed. 2008; 24(1):19-23.
Johnsson M, Falk ES. Volden G. UVB treatment of factitious urticaria. Photodermatol. 1987;4(6):302-304.
Logan RA, O’Brien TJ. Greaves MW. The effect of psoralen photochemotherapy (PUVA) on symptomatic dermographism. Clin Exp Dermatol. 1989;14(1):25-28.
Parker RK, Crowe MJ, Guin JD. Aquagenic urticaria. Cutis. 1992;50(4):283-284.
Juhlin L, Malmros-Enander I. Familial polymorphous light eruption with aquagenic urticaria: successful treatment with PUVA. Photodermatol. 1986;3(6):346-349.
Hönigsmann H. Mechanisms of phototherapy and photochemotherapy for photodermatoses. Dermatol Ther. 2003;16(1):23-27.
Väätäinen N, Hannuksela M, Karvonen J. Trioxsalen baths plus UV-A in the treatment of lichen planus and urticaria pigmentosa. Clin Exp Dermatol. 1981;6(2):133-138.
Godt O, Proksch E, Streit V, Christophers E. Short- and long-term effectiveness of oral and bath PUVA therapy in urticaria pigmentosa and systemic mastocytosis. Dermatology. 1997;195(1):35-39.
Gobello T, Mazzanti C, Sordi D, et al. Medium versus high-dose ultraviolet A1 therapy for urticaria pigmentosa: a pilot study. J Am Acad Dermatol. 2003;49(4):679-684.
Yosipovitch G, Goon A, Wee J, Chan YH, Goh CL. The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis. Br J Dermatol. 2000;143(5):969-973.
Amatya B, Nordlind K. Focus groups in Swedish psoriatic patients with pruritus. J Dermatol. 2008;35(1):1-5.
Lowe NJ, Cripps DJ, Dufton PA, Vickers CF. Photo-chemotherapy for mycosis fungoides: a clinical and histological study. Arch Dermatol. 1979;115(1):50-53.
Pujol RM, Gallardo F, Llistosella E, et al. Invisible mycosis fungoides: a diagnostic challenge. J Am Acad Dermatol. 2000;42(2 pt 2):324-328.
Clark C, Dawe RS, Evans AT, Lowe G, Ferguson J. Narrowband TL-01 phototherapy for patch-stage mycosis fungoides. Arch Dermatol. 2000;136(6):748-752.
von Kobyletzki G, Dirschka T, Freitag M, Hoffman K, Altmeyer P. Ultraviolet-A1 phototherapy improves the status of the skin in cutaneous T-cell lymphoma. Br J Dermatol. 1999;140(4):768-769.
Wallengren J. Prurigo: diagnosis and management. Am J Clin Dermatol. 2004;5(2):85-95.
Clark AR, Jorizzo JL, Fleischer AB. Papular dermatitis (subacute prurigo, “itchy red bump” disease): pilot study of phototherapy. J Am Acad Dermatol. 1998;38(6 pt 1):929-933.
Streit V, Thiede R, Wiedow O, Christophers E. Foil bath PUVA in the treatment of prurigo simplex subacuta. Acta Derm Venereol. 1996;76(4):319-320.
Gambichler T, Hyun J, Sommer A, Stücker M, Altmeyer P, Kreuter A. A randomised controlled trial on photo(chemo)therapy of subacute prurigo. Clin Exp Dermatol. 2006;31(3):348-353.
Väätäinen N, Hannuksela M, Karvonen J. Local photochemotherapy in nodular prurigo. Acta Derm Venereol. 1979;59(6):544-547.
Hann SK, Cho MY, Park YK. UV treatment of generalized prurigo nodularis. Int J Dermatol. 1990;29(6):436-437.
Divekar PM, Palmer RA, Keefe M. Phototherapy in nodular prurigo. Clin Exp Dermatol. 2003;28(1):99-100.
Tamagawa-Mineoka R, Katoh N, Ueda E, Kishimoto S. Narrow-band ultraviolet B phototherapy in patients with recalcitrant nodular prurigo. J Dermatol. 2007;34(10):691-695.
Fantini F, Baraldi A, Sevignani C, Spattini A, Pincelli C, Giannetti A. Cutaneous innervation in chronic renal failure patients. An immunohistochemical study. Acta Derm Venereol. 1992;72(2):102-105.
Johansson O, Hilliges M, Ståhle-Bäckdahl M. Intraepidermal neuron-specific enolase (NSE)-immunoreactive nerve fibres: evidence for sprouting in uremic patients on maintenance hemodialysis. Neurosci Lett. 1989;99(3):281-286.
Milazzo F, Piconi S, Trabattoni D, et al. Intractable pruritus in HIV infection: immunologic characterization. Allergy. 1999;54(3):266-272.
Vaalasti A, Suomalainen H, Rechardt L. Calcitonin gene-related peptide immunoreactivity in prurigo nodularis: a comparative study with neurodermatitis circumscripta. Br J Dermatol. 1989;120(5):619-623.
Bergasa NV. The pruritus of cholestasis. J Hepatol. 2005;43(6):1078-1088.
Fjellner B, Hägermark O. Pruritus in polycythemia vera: treatment with aspirin and possibility of platelet involvement. Acta Derm Venereol. 1979;59(6):05-12.
Stahle-Backdahl M. Uremic pruritus: clinical and experimental studies. Acta Derm Venereol. 1989;145(suppl):1-38.
Gilchrest BA, Rowe JW, Brown RS, Steinman TI, Arndt KA. Relief of uremic pruritus with ultraviolet phototherapy. N Engl J Med. 1977;297(3):136-138.
Simpson NB, Davison AM. Ultraviolet phototherapy for uraemic pruritus. Lancet. 1981;1(8223):781.
Blachley JD, Blankenship DM, Menter A, Parker TF 3rd, Knochel JP. Uremic pruritus: skin divalent ion content and response to ultraviolet phototherapy. Am J Kidney Dis. 1985;5(5):237-241.
Seckin D, Demircay Z, Akin O. Generalized pruritus treated with narrowband UVB. Int J Dermatol. 2007;46(4):367-370.
Martin J. Pruritus. Int J Dermatol. 1985;24(10):634-639.
Hanid MA, Levi AJ. Phototherapy for pruritus in primary biliary cirrhosis. Lancet. 1980;2(8193):530.
Perlstein SM. Phototherapy for primary biliary cirrhosis. Arch Dermatol. 1981;117(10):608.
Person JR. Ultraviolet A (UV-A) and cholestatic pruritus. Arch Dermatol. 1981;117(11):684.
Johnston WG, Baskett TF. Obstetric cholestasis. A 14 year review. Am J Obstet Gynecol. 1979;133(3):299-301.
Tauscher AE, Fleischer AB Jr, Phelps KC, Feldman SR. Psoriasis and pregnancy. J Cutan Med Surg. 2002;6(6):561-570.
Baldo A, Sammarco E, Plaitano R, Martinelli V. Monfrecola. Narrowband (TL-01) ultraviolet B phototherapy for pruritus in polycythaemia vera. Br J Dermatol. 2002;147(5):979-981.
Swerlick RA. Photochemotherapy treatment of pruritus associated with polycythemia vera. J Am Acad Dermatol. 1985;13(4):675-677.
Jeanmougin M, Rain JD, Najean Y. Efficacy of photochemotherapy on severe pruritus in polycythemia vera. Ann Hematol. 1996;73(2):91-93.
Menagé HD, Norris PG, Hawk JL. Graves MW. The efficacy of psoralen photo-chemotherapy in the treatment of aquagenic pruritus. Br J Dermatol. 1993;129(2):163-165.
Steinman HK, Greaves MW. Aquagenic pruritus. J Am Acad Dermatol. 1985;13(1):91-96.
Smith RA, Ross JS, Staughton RC. Bath PUVA as a treatment for aquagenic pruritus. Br J Dermatol. 1994;131(4):584.
Gelfand JM, Rudikoff D. Evaluation and treatment of itching in HIV-infected patients. Mt Sinai J Med. 2001;68(4-5):298-308.
Gorin I, Lessana-Leibowitch M, Fortier P, Leibowitch J, Escande JP. Successful treatment of the pruritus of human immunodeficiency virus infection and acquired immunodeficiency syndrome with psoralens plus ultraviolet A therapy. J Am Acad Dermatol. 1989;20(3):511-513.
Weiss DS, Taylor JR. Treatment of generalized pruritus in an HIV-positive patient with UVB phototherapy. Clin Exp Dermatol. 1990;15(4):316-317.
Lim HW, Vallurupalli S, Meola T, Soter NA. UVB phototherapy is an effective treatment for pruritus in patients infected with HIV. J Am Acad Dermatol. 1997;37(3 pt 1):414-417.
Akaraphanth R, Lim HW. HIV, UV and immunosuppression. Photodermatol Photoimmunol Photomed. 1999;15(1):28-31.
Ward JR, Bernhard JD. Willan’s itch and other causes of pruritus in the elderly. Int J Dermatol. 2005;44(4):267-273.
Lonsdale-Eccles A. Carmichael AJ. Treatment of pruritus associated with systemic disorders in the elderly: a review of the role of new therapies. Drugs Aging. 2003;20(3):197-208.
Lindelöf B, Sigurgeirsson B, Tegner E, et al. PUVA and cancer risk: the Swedish follow-up study. Br J Dermatol. 1999;141(1):108-112.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag London Limited
About this chapter
Cite this chapter
Wallengren, J. (2010). Ultraviolet Phototherapy of Pruritus. In: Misery, L., Ständer, S. (eds) Pruritus. Springer, London. https://doi.org/10.1007/978-1-84882-322-8_51
Download citation
DOI: https://doi.org/10.1007/978-1-84882-322-8_51
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-84882-321-1
Online ISBN: 978-1-84882-322-8
eBook Packages: MedicineMedicine (R0)